Sunday, November 8, 2026

USD/CNH Bearish Momentum With A 4% Drop In The Last 21 Sessions

ViaNews Editorial Team

February 16, 2023

USD/CNH Bearish Momentum With A 4% Drop In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 4.2% for the last 21 sessions. At 18:07 EST on Thursday, 16 February, USD/CNH (USDCNH) is $6.87.

USD/CNH's yearly highs and lows, it's 0.068% up from its 52-week low and 0.019% down from its 52-week high.

News about

  • Usd/jpy tracks downbeat yields, hawkish boj concerns near 132.00, focus on US inflation. According to FXStreet on Tuesday, 14 February, "Following that, the official nomination of Kazuo Ueda as the BoJ leader weighed on the USD/JPY prices. ", "Moving on, the market consensus anticipates 6.2% YoY print of the US CPI for January but the odds of the positive surprise during the year-start are high, which in turn keeps USD/JPY bears on the dicey floor."
  • Usd/jpy reclaims 133.00 after mixed January’s US CPI report. According to FXStreet on Tuesday, 14 February, "In an alternate scenario, the USD/JPY struggling to hold above 133.00 would open the door toward the 50-day EMA At 132.67, ahead of the 132.00 figure.", "After hitting a daily low of 131.49, the USD/JPY encountered some buyers around the latter, rallying sharply towards 133.00, underpinned by the US 10-year Treasury bond yield. "
  • Usd/jpy stays above 132.00 on Japan gdp, boj nominations, US inflation eyed. According to FXStreet on Tuesday, 14 February, "That said, the Japanese government is up for formally announcing their nominations for the BoJ leadership on Tuesday, making Bloomberg's piece important for the USD/JPY pair traders.", "Following the data, the USD/JPY pair bounced off its intraday low before reversing to 132.25 by the press time."
  • Usd/jpy: correction from six-week highs stalls near 132.50, US data eyed. According to FXStreet on Wednesday, 15 February, "The rush to safety in the US bond market is sending the US Treasury bond yields lower, in turn, weighing down on the USD/JPY pair.", "From a short-term technical perspective, USD/JPY is reattempting the 133.00 level, having found support near the 132.50 psychological level."
  • Usd/jpy price analysis: bulls flirt with 133.00 inside monthly rising wedge. According to FXStreet on Wednesday, 15 February, "It should be noted that the 130.00 round figure will act as an extra filter towards the south of 130.60 before directing the USD/JPY sellers towards the theoretical target of the stated wedge, namely 125.50.", "That said, the USD/JPY remains inside a one-month-old rising wedge bearish chart formation."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com